BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16039404)

  • 1. Endometrial cancer--surprising reports.
    Speroff L
    Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial adenocarcinoma after prolonged tibolone therapy.
    Nassar AH; Khalil AM; Seoud MA; Usta IM
    Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
    [No Abstract]   [Full Text] [Related]  

  • 3. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Million Women Study--is it believable?
    Farmer R
    Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
    [No Abstract]   [Full Text] [Related]  

  • 6. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LIBERATE tibolone trial in breast cancer survivors.
    Speroff L
    Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
    [No Abstract]   [Full Text] [Related]  

  • 8. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
    Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
    J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
    [No Abstract]   [Full Text] [Related]  

  • 9. Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies.
    Coomarasamy A
    BJOG; 2008 Jun; 115(7):919. PubMed ID: 18485174
    [No Abstract]   [Full Text] [Related]  

  • 10. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of the endometrium in patients treated with tibolone.
    Yazigi R; Sahid S; Contreras L; Rodriguez T
    Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in women with past history of endometriosis.
    Soliman NF; Hillard TC
    Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone therapy effect in postmenopausal women with history of endometrial cancer].
    Arteaga-Gómez AC; Castellanos-Barroso G; Colin-Valenzuela A; García-Vargas J; Márquez-Acosta G; Reyes-Muñoz E
    Ginecol Obstet Mex; 2011 Jan; 79(1):11-7. PubMed ID: 21966778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some comments on the Million Women Study.
    Neves-E-Castro M
    Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones and endometrial cancer--new data from the Million Women Study.
    Brinton LA; Lacey JV; Trimble EL
    Lancet; 2005 Apr 30-May 6; 365(9470):1517-8. PubMed ID: 15866289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C; Bourg F; Legeai J; Senoussi S
    Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer and hormone-replacement therapy.
    Wiegratz I; Kuhl H
    Lancet; 2005 Jul 16-22; 366(9481):201-2. PubMed ID: 16023504
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy, breast and endometrial cancer.
    La Vecchia C
    Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormones and cancer.
    Shang Y
    Cell Res; 2007 Apr; 17(4):277-9. PubMed ID: 17426695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.